期刊文献+

脑肿瘤术中应用右旋美托咪啶对芬太尼剂量及血流动力学的影响 被引量:5

Effect of Dexmedetomidine on the Intraoperative Fentanyl Requirements and Perioperative Hemodynamics in Patients Undergoing Intracranial Tumor Surgery
原文传递
导出
摘要 目的观察脑肿瘤术中应用右旋美托咪啶对芬太尼剂量及血流动力学的影响。方法选择30例ASAⅠ-Ⅱ级欲行脑肿瘤切除术患者,随机分成右旋美托咪啶组和安慰剂组,右旋美托咪啶组给予负荷剂量0.5μg.kg 1(20 min)的右旋美托咪啶,然后0.9μg.kg 1.h 1泵注,安慰剂组则给予同一容量和外形相似的生理盐水。观察术中麻醉药的用量和血流动力学变化。结果右旋美托咪啶组术中芬太尼用量、麻醉诱导后40 min内及术终的心率、平均压与安慰剂组相比显著降低;麻醉诱导60 min后的七氟烷呼末浓度右旋美托咪啶组与安慰剂组相比明显降低。结论脑肿瘤术中应用右旋美托咪啶可降低术中心率和平均压,并减少麻醉药用量。 OBJECTIVE To assess the effect of dexmedetomidine on the intraoperative fentanyl requirements and perioperative hemodynamics in patients undergoing intracranial tumor surgery. METHODS Thirty patients scheduled for intracranial tumor surgery were recruited, randomized assigned into receive dexmedetomidine or placebo groups, D and P, respectively. In group D patients received a loading dose of dexmedetomidine 0.5 μg·kg-1 over 20 minutes, followed by a continuous infusion of a rate of 0.9 μg·kg-1·h-1. In group P, patients received a volume matched 0.9% saline. Opioid requirement, heart rate (HR), blood pressure (BP) and end-tidal sevoflurane concentration were monitored. RESULTS The fentanyl consumption was 436.7, 663.3 μg in the D and P groups, respectivly (P〈0.05 for comparison of the D and P group). From the anesthesia induction to 40 min after anesthesia induction, the D group had slower heart rate and lower mean arterial blood pressure .The end-tidal sevoflurane concentration was lower in the D group after 60 min of anesthesia induction. CONCLUSION Intraoperative dexmedetomidine infusion significantly decreases fentanyl and sevoflurane consumption, increases intraoperative haemodynamic stability during intracranial tumor surgery.
机构地区 浙江省人民医院
出处 《中国现代应用药学》 CAS CSCD 2012年第2期173-175,共3页 Chinese Journal of Modern Applied Pharmacy
关键词 脑肿瘤术 右旋美托咪啶 芬太尼 血流动力学 intracranial tumor surgery dexmedetomidine fentanyl perioperative hemodynamics
  • 相关文献

参考文献8

  • 1何莉,佘守章,阮祥才.右旋美托嘧啶对舒芬太尼-丙泊酚靶控输注效应的影响[J].国际麻醉学与复苏杂志,2008,29(5):391-395. 被引量:42
  • 2NISHIKAWA T. Risk management for neurosurgical anesthesia [J]. Masui, 2009, 58(5): 545-551.
  • 3ROZET I, VAVILALA M S, L1NDLEY A M, et al. Cerebral autoregulation and CO2 reactivity in anterior and posterior cerebral circulation during sevoflurane anesthesia [J]. Anesth Analg, 2006, 102(2): 560-564.
  • 4BEKKER A, STURAITIS M, BLOOM M, et al. The effect of dexmedetomidine on perioperative hemodynamics in patients undergoing craniotomy [J]. Anesth Analg, 2008, 107(4): 1340- 1347.
  • 5TANSKANEN P E, KYTTA J V, RANDELL T T, et al. Dexmedetomidine as an anaesthetic adjuvant in patients undergoing intracranial tumour surgery: a double-blind, randomized and placebo-controlled study[J]. Br J Anaesth, 2006, 97(5):658-665.
  • 6SOUZA S S, INTELISANO T R, DE BIAGGI C P, et al. Cardiopulmonary and isoflurane-sparing effects of epidural or intravenous infusion of dexmedetomidine in cats undergoing surgery with epidural lidocaine [J]. Vet Anaesth Analg, 2010, 37(2): 106-115.
  • 7LIN H, FARAKLAS I, SAMPSON C, et al. Use of dexmedetomidine for sedation in critically ill mechanically ventilated pediatric bum patients [J]. J Bum Care Res, 2011, 32(1): 98-103.
  • 8SATO K, KIMURA T, NISHIKAWA T, et al. Neuroprotective effects of a combination of dexmedetomidine and hypothermia after incomplete cerebral ischemia in rats [J]. Acta Anaesthesiol Scand, 2010, 54(3): 377-382.

二级参考文献11

  • 1Daniel L, Herr S, John SP, et al. ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. Journal of Cardiothoracic and Vascular Anesthesia, 2003, 17: 576-584.
  • 2Maldonado JR, Starre P, Wysong A. The role of the novel anesthetic agent dexmedetomidine on reduction of the incidence of ICU delirium in postcardiotomy patients. Journal of Psychosomatic Research, 2003, 55 : 150.
  • 3Gepts E, Shafer SL, Camu F, et al. Linearity of pharmacokinetics and model estimation of sufentanil. Anesthesiology, 1995, 83: 1194-1204.
  • 4Marsh B, White M, Morton N, et al. Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth, 1991,67 : 4148.
  • 5Talke P. Pharmacodynamics of alpha2-adrenoceptor agonists. Bailliere's Clinical Anaesthesiology, 2000, 14: 271-283.
  • 6Scheinin B, Lindgren L, Randell T, et al. Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl. Br J Anaesth, 1992, 68: 126-131.
  • 7Scheinin H, Jaakola ML, Sjovall S, et al. Intramuscular dexmedetomidine as premedication for general anesthesia. A comparative multicenter study. Anesthesiology, 1993, 78: 1065-1075.
  • 8Talke P, Chen R, Thomas B, et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg, 2000, 90: 834-839.
  • 9Mendes GM, Selmi AL, Barbudo-Seimi GR, et al. Effect of dexmedetomidiue as premedicant in cats undergoing propofol-sevoflurane anaesthesia. J Feline Med Surg, 2003, 5: 265-270.
  • 10Klan ZP, Munday IT, Jones RM, et al. Effects of dexmedetomidine on isoflurane requirements in health volunteers : pharmacodynamic and phaimacokinetic interactions. Br J Anaesth, 1999, 83 : 372-380.

共引文献41

同被引文献62

  • 1李丽伶,孟轶男,吴群,吴辉,吴进泽.酒石酸布托啡诺复合丙泊酚对无痛肠镜病人的影响[J].中国临床药理学与治疗学,2008,13(9):1062-1065. 被引量:9
  • 2Leriger M, Naguib A, Gallantowicz M, et al. Dexmedetomidine con- trols junctional ectopic tachycardia during Tetralogy of Fallot repair in an infant. Ann Card Anaesth,2012,15(3):224-248.
  • 3Ammar AS, Mahmoud KM. Ultrasound-guided single injection in- fraclavicular brachial plexus block using bupivacaine alone or combined with dexmedetomidine for pain control in upper limb surgery: a prospective randomized controlled trial. Saudi J An- aesth. 2012,6(2) :109-114.
  • 4Keating GM, Hoy SM, Lyseng-Williamson KA. Dexmedetomidine : a guide to its use for sedation in the US. Clin Drug Investig, 2012,32 ( 8 ) :561-567.
  • 5Okamoto T, Mori T, Takeda T, et al. Dexmedetomidine is an ex- cellent sedative for voice monitoring surgery. Masui, 2012, 61 (5) :542-545.
  • 6Bajwa SJ, Kaur J, Singh A, et al. Attenuation of pressor response and dose sparing of opioids and anaesthetics with pre-operative dexmedetomidine. Indian J Anaesth ,2012,56 (2) : 123-128.
  • 7Ozturk L, Arslan M, Comu FM. The effects of low-high doses of dexmedetomidine on erythrocyte deformability in rats. Bratisl Lek Listy,2012,113 ( 6 ) :347-349.
  • 8El-Tahan MR, Mowafi HA, Al Sheikh IH, et al. Efficacy of dexmedetomidine in suppressing cardiovascular and hormonal re- sponses to general anaesthesia for caesarean delivery:a dose-re- sponse study. Int J Obstet Anesth,2012,21 (3) :222-229.
  • 9Su F, Hammer GB. Dexmedetomidine: pediatric pharmacology, clinical uses and safety. Expert Opin Drug Saf.2O 11 ;10(1 ):55-66.
  • 10Le M, Liu N, Tounou F, et al. Dexmedetomidine reduces propofol and remifentanil requirements during bispectral index-guided closed-loop anesthesia: a double-blind, placebo-controlled trial. Anesth Analg.2014;118(5): 946-955.

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部